产品描述
| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 产品介绍 | Vernakalant(RSD-1235)是混合型离子通道阻断剂，在2到5 mg/kg剂量下，能终止急性心房颤动。 |
| 生化机理 |
Vernakalant is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents. In treatment of antiarrhythmic |
| 别名 | RSD1235;RSD 1235;RSD-1235;RSD1235;RSD 1235;RSD-1235；Vemakalant |
